<scp> <i>PCDHGC3</i> </scp> hypermethylation as a potential biomarker of intestinal neuroendocrine carcinomas

Tamara Cubiella, Lucía Celada, Jaime San‐Juan‐Guardado, Raúl Rodríguez‐Aguilar, Álvaro Suárez‐Priede, María Poch, Francisco Dominguez, Iván Fernández‐Vega, Pedro Montero‐Pavón, Mario F Fraga, Yoichiro Nakatani, So Takata, Shinichi Yachida, Nuria Valdés, María‐Dolores Chiara

Open source

DOI: 10.1002/path.6291
Published: 2024-05-25
Container: The Journal of Pathology
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/path.6291,
  title = {<scp>
                      <i>PCDHGC3</i>
                    </scp>
                    hypermethylation as a potential biomarker of intestinal neuroendocrine carcinomas},
  author = {Tamara Cubiella and Lucía Celada and Jaime San‐Juan‐Guardado and Raúl Rodríguez‐Aguilar and Álvaro Suárez‐Priede and María Poch and Francisco Dominguez and Iván Fernández‐Vega and Pedro Montero‐Pavón and Mario F Fraga and Yoichiro Nakatani and So Takata and Shinichi Yachida and Nuria Valdés and María‐Dolores Chiara},
  year = {2024},
  journal = {The Journal of Pathology},
  doi = {10.1002/path.6291},
  url = {https://doi.org/10.1002/path.6291}
}

RIS

TY  - JOUR
TI  - <scp>
                      <i>PCDHGC3</i>
                    </scp>
                    hypermethylation as a potential biomarker of intestinal neuroendocrine carcinomas
AU  - Tamara Cubiella
AU  - Lucía Celada
AU  - Jaime San‐Juan‐Guardado
AU  - Raúl Rodríguez‐Aguilar
AU  - Álvaro Suárez‐Priede
AU  - María Poch
AU  - Francisco Dominguez
AU  - Iván Fernández‐Vega
AU  - Pedro Montero‐Pavón
AU  - Mario F Fraga
AU  - Yoichiro Nakatani
AU  - So Takata
AU  - Shinichi Yachida
AU  - Nuria Valdés
AU  - María‐Dolores Chiara
PY  - 2024
JO  - The Journal of Pathology
DO  - 10.1002/path.6291
UR  - https://doi.org/10.1002/path.6291
ER  -

APA

Cubiella, T., Celada, L., San‐Juan‐Guardado, J., Rodríguez‐Aguilar, R., Suárez‐Priede, Á., Poch, M., Dominguez, F., Fernández‐Vega, I., Montero‐Pavón, P., Fraga, M. F., Nakatani, Y., Takata, S., Yachida, S., Valdés, N., & Chiara, M. (2024). <scp> <i>PCDHGC3</i> </scp> hypermethylation as a potential biomarker of intestinal neuroendocrine carcinomas. The Journal of Pathology. https://doi.org/10.1002/path.6291

Source records

crossref · retrieved 2026-09-27T16:19:41.910Z